---
title: "Abbott Laboratories and others v DexCom, Inc (UPC CoA 5/2024, 14-03-2024)"
description: "The President of the Court of Appeal rejected as inadmissible Abbott's appeal against a confidentiality order of the Paris Local Division, because the Court of…"
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-5-2024-2024-03-14
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:09.356Z
dateModified: 2026-11-18T10:07:09.356Z
---

# Abbott Laboratories and others v DexCom, Inc

Order of the UPC Court of Appeal of 14 March 2024, UPC CoA 5/2024.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The President of the Court of Appeal rejected as inadmissible Abbott's appeal against a confidentiality order of the Paris Local Division, because the Court of First Instance had not granted leave to appeal. An appeal under R 220.2 RoP filed without leave is inadmissible from the outset and cannot be withdrawn. An appellant cannot avoid a formal inadmissibility ruling by withdrawing the appeal.

## Key holding

Under R 220.2 RoP, orders other than those referred to in R 220.1 and R 97.5 RoP may be appealed only if the Court of First Instance has granted leave to appeal. An appeal from such an order filed without leave is inadmissible from the outset and, as such, cannot be withdrawn; it is rejected as inadmissible. Where the Registry has already heard the appellant on whether leave was granted, the appellant need not be heard again before rejection (R 229.5, second sentence, RoP).

## Questions decided

1. Is an appeal under R 220.2 RoP admissible without leave from the Court of First Instance?
2. Can an appeal that is inadmissible from the outset for lack of leave be withdrawn?
3. Must the appellant be heard again before rejection under R 229.5 RoP if the Registry has already heard it?

## Case details

- Court: Court of Appeal of the Unified Patent Court, President of the Court of Appeal
- Panel: Klaus Grabinski, President of the Court of Appeal (deciding judge)
- Date: 14-03-2024
- Case number(s): UPC CoA 5/2024, UPC CFI 230/2023
- Parties: Appellants: Abbott Laboratories, Abbott Diabetes Care Inc., Abbott France, Abbott (S.V./N.V.), Abbott B.V., Abbott S.r.l., Abbott Scandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics GmbH and Abbott Logistics B.V. (defendants at first instance); Respondent: DexCom, Inc (claimant at first instance)
- Language of the proceedings: English
- Outcome: The appeal is rejected as inadmissible. The order contains no costs order.
- Official text on the court’s website (PDF): https://www.unified-patent-court.org/sites/default/files/files/api_order/32F3738613007CB6B5F4AC07A5CB2530_en.pdf

## How to cite

Court of Appeal, Abbott Laboratories and others v DexCom, Inc, UPC CoA 5/2024, Order of 14 March 2024 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-5-2024-2024-03-14

Topics: [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [DexCom, Inc. v Abbott Laboratories and others, UPC CoA 505/2024, 24-01-2025](https://pitch.law/academy/upc-court-of-appeal/upc-coa-505-2024-2025-01-24): The Court of Appeal held that parties may withdraw an infringement action and the counterclaims for revocation under R 265 RoP while an appeal is pending, and it permitted both withdrawals and closed the proceedings.

## More on procedure

- [PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others, UPC CoA 163/2026, 11-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-163-2026-2026-11-11): The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- [The Walt Disney Company and others v InterDigital VC Holdings, Inc., UPC CoA 133/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-133-2026-2026-11-05): A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- [Guardant Health, Inc. v Sophia Genetics SA and others, UPC CoA 49/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-49-2026-2026-11-05): The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- [Netflix Services Germany GmbH and others v DivX, LLC, UPC CoA 176/2026, 02-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-176-2026-2026-11-02): The Court of Appeal refused Netflix's request for suspensive effect against the Munich Local Division's infringement decision in favour of DivX, even though the EPO Opposition Division revoked the patent after that decision.
- [Appellant (name not stated) v Amycel, LLC, UPC CoA 935/2025, 02-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-935-2025-2026-11-02): The Court of Appeal set aside a decision by default of The Hague Local Division and allowed the defendant's application to have it set aside under R 356 RoP.
